alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                                          5
<MULTIPLIER>                                       1
<CURRENCY>                                         U.S. DOLLARS

<S>                                                <C>
<PERIOD-TYPE>                                      9-MOS
<FISCAL-YEAR-END>                                  DEC-31-1999
<PERIOD-START>                                     JAN-01-1999
<PERIOD-END>                                       SEP-30-1998
<EXCHANGE-RATE>                                    1
<CASH>                                                  15,930
<SECURITIES>                                                 0
<RECEIVABLES>                                        1,655,075
<ALLOWANCES>                                          (302,679)
<INVENTORY>                                            291,731
<CURRENT-ASSETS>                                     3,271,798
<PP&E>                                               1,099,185
<DEPRECIATION>                                        (623,388)
<TOTAL-ASSETS>                                       3,805,621
<CURRENT-LIABILITIES>                                2,513,325
<BONDS>                                                      0
<PREFERRED-MANDATORY>                                        0
<PREFERRED>                                                  0
<COMMON>                                                61,035
<OTHER-SE>                                                   0
<TOTAL-LIABILITY-AND-EQUITY>                         3,805,621
<SALES>                                              6,117,875
<TOTAL-REVENUES>                                     6,117,875
<CGS>                                                4,330,578
<TOTAL-COSTS>                                        4,330,578
<OTHER-EXPENSES>                                     2,488,542
<LOSS-PROVISION>                                             0
<INTEREST-EXPENSE>                                     153,339
<INCOME-PRETAX>                                       (840,162)
<INCOME-TAX>                                                 0
<INCOME-CONTINUING>                                   (840,162)
<DISCONTINUED>                                               0
<EXTRAORDINARY>                                              0
<CHANGES>                                                    0
<NET-INCOME>                                          (840,162)
<EPS-BASIC>                                            (0.04)
<EPS-DILUTED>                                            (0.04)



</TABLE>
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsA Comparison of Neural Networks and Fuzzy Logic Methods for Process ModelingThe goal of this work was to analyze the potential of neural networks and fuzzy logic methods to develop approximate response surfaces as process modeling, that is for mapping of input into output. Structural response was chosen as an example. Each of the many methods surveyed are explained and the results are presented. Future research directions are also discussed.Document ID19960047083Acquisition SourceLegacy CDMSDocument TypeTechnical Memorandum (TM)AuthorsCios, Krzysztof J.*(Toledo Univ. OH United States)*Sala, Dorel M.*(Toledo Univ. OH United States)*Berke, Laszlo*(NASA Lewis Research Center Cleveland, OH United States)*Date AcquiredSeptember 6, 2013Publication DateJuly 1, 1996Subject CategoryNumerical AnalysisReport/Patent NumberNASA-TM-107236NAS 1.15:107236E-10280Accession Number96N32865Funding Number(s)PROJECT: RTOP 505-90-00Distribution LimitsPublicCopyrightWork of the US Gov. Public Use Permitted.Available DownloadsNameType19960047083.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
|   |   |
|--------|--------|

**Filed      Pursuant To Rule 433, Registration No. 333-124310**
** **

**$1,000,000,000**

**CATERPILLAR      FINANCIAL SERVICES CORPORATION**

| **For                the Period: 5/7/2007 to 5/14/2007** |
|----------------------------------------------------------|
| **Coupon**                                               | **Interest** | **Maturity** | **Callable** | **Survivor's****Option** | **Price****1** | **Yield****2** | **Moody's** | **S&P** | **CUSIP** |
| 4.850%                                                   | Semi-Annual(†††) | 5/15/09 | NO | YES§  | 100.00 | 4.850% | A2 | A | 14912HCU2 |
| 5.400%                                                   | Semi-Annual(†††) | 5/15/17 | 5/15/09***  | YES§  | 100.00 | 5.400% | A2 | A | 14912HCV0 |
| 5.600%                                                   | Semi-Annual(†††) | 5/15/22 | 5/15/10***  | YES§  | 100.00 | 5.600% | A2 | A | 14912HCW8 |
| 5.700%                                                   | Semi-Annual(†††) | 5/15/27 | 5/15/11***  | YES§  | 100.00 | 5.700% | A2 | A | 14912HCX6 |

*All      offerings are subject to prior sale.*
From: mnewburg7@gmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:12:44 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Thank you for your consideration of this important topic to face American Families!

Sincerely,

Mark Newburg

Winterville, NC 28590
#### UNITED STATES of America, Plaintiff—Appellee, v. Shayne M. CRISOLO, Defendant—Appellant.

No. 04-10317.

United States Court of Appeals, Ninth Circuit.

Submitted Aug. 1, 2005.*

Decided Aug. 15, 2005.

*654Constance Hassell, Office of the U.S. Attorney, Honolulu, HI, for Plaintiff-Appellee.

Shawn A. Luiz, Esq., Honolulu, HI, for Defendant-Appellant.

Before: O’SCANNLAIN, CALLAHAN, and BEA, Circuit Judges.

*

 This panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Shayne Crisolo appeals his sentence imposed after his guilty plea to aiding and abetting the attempted possession of methamphetamine with intent to distribute, in violation of 21 U.S.C. § 841(a)(1) and 18 U.S.C. § 2. He contends that the district court erred in refusing to depart downward from the United States Sentencing Guidelines for sentencing disparity.

Crisolo was sentenced before the Supreme Court held that the Sentencing Guidelines were effectively advisory. *See United States v. Booker,*— U.S. -, -, 125 S.Ct. 738, 764, 160 L.Ed.2d 621 (2005). The discretionary denial of a downward departure under the *pre-Booker*mandatory Guidelines is unreviewable. *See United States v. Linn,*362 F.3d 1261, 1262 (9th Cir.2004) (per curiam). Nonetheless, the record does not show how the district court would have proceeded had it known that the Guidelines were not mandatory. Accordingly, we remand for the district court to answer the question whether the sentence would have been materially different if it had known that the Guidelines were advisory and for further proceedings under *United States v. Ameline,*409 F.3d 1073, 1084-85 (9th Cir.2005) (en banc). *See United States v. Moreno-Hernandez,*419 F.3d 906 (9th Cir.2005) (amended opinion).

REMANDED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
EXHIBIT 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with the  Quarterly  Report of The  Players  Network  (the
"Company")  on Form 10-QSB for the quarter ended June 30, 2004 as filed with the
Securities  and  Exchange   Commission  on  August  23,  2004  ("Report"),   the
undersigned,  in the capacity and on the date indicated below,  hereby certifies
pursuant  18 U.S.C.  Section  1350,  as adopted  pursuant  to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

            1. The Report fully complies with the  requirements of Section 13(a)
      or 15(d) of the Securities Exchange Act of 1934; and

            2. The information  contained in the Report fairly presents,  in all
      material  respects,  the financial  condition and results of operations of
      the Company.


Dated: August 23, 2004

                                                 /s/ Mark Bradley
                                                 -------------------------------
                                                 Mark Bradley
                                                 Chief Executive Officer


<PAGE>

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with the  Quarterly  Report of The  Players  Network  (the
"Company")  on Form 10-QSB for the quarter ended June 30, 2004 as filed with the
Securities  and  Exchange   Commission  on  August  23,  2004  ("Report"),   the
undersigned,  in the capacity and on the date indicated below,  hereby certifies
pursuant  18 U.S.C.  Section  1350,  as adopted  pursuant  to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

      1. The Report fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      2.  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


Dated: August 23, 2004

                                                 /s/ Seth Horn
                                                 -------------------------------
                                                 Seth Horn
                                                 Chief Financial Officer
From: rec35@sbcglobal.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:38:40 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Robert Cunningham

Dallas, TX 75205
[Federal Register Volume 88, Number 185 (Tuesday, September 26, 2023)]
[Notices]
[Page 66014]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20876]



[[Page 66014]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIHAI75N93023R00003: Pre-clinical 
Models of Infectious Diseases--Task Area A.
    Date: October 20-27, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Rockville, MD 
20892 (Virtual Meeting).
    Contact Person: Rekha Dhanwani, Ph.D., Scientific Review 
Program, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, MSC 9834, 
Rockville, MD 20852, (240) 627-3076 <a href="/cdn-cgi/l/email-protection#a0d2c5cbc8c18ec4c8c1ced7c1cec9e0cec9c88ec7cfd6"><span class="__cf_email__" data-cfemail="5022353b38317e3438313e27313e39103e39387e373f26">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 20, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20876 Filed 9-25-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# 

# CATERPILLAR FINANCIAL SERVICES CORPORATION

POWERNOTES (SM)

With Maturities of 9 months or more from Date of Issue

Registration No.  333-97047

Filed Pursuant to Rule 424 (b) (3)

PRICING SUPPLEMENT NO.  356                                                               Trade Date:  11/03/03

(To Prospectus Supplement dated August 15, 2002 &

  Prospectus dated August  8, 2002)                                                                     Issue Date:   11/06/03

The Date of this Pricing SupplementNovember 3, 2003

SUBJECT TO REDEMPTION OR REPAYMENT

  CUSIP                                                                                                                                Date and terms of redemption or

     or        Stated                                                                  Interest                                    repayment (including any

Common  Interest                      Price to  Discounts &        Payment  Survivors                  applicable regular or special

  Code      Rate (1)               Maturity                Public (2)                Commissions      Frequency      Option     Yes/No                record dates)

14911QQV6   4.1%                        05/15/11          100%                    1.15%                  Quarterly           YES           NO                                        

                       

                          

Principal                                                                                1st Payment Day         

Amount                   Proceeds                 Dealer                            Date                  Count

$580,000.00                $573,330.00            ABN AMROInc.                 02/15/04                 30/360    

Original Issue Discount Note:                                                                   Total Amount of OID:

____  Yes                X   No                                                                                   N/A

The interest rates on the PowerNotes (SM) may be changed by Caterpillar Financial Services Corporation from time to time, but any such change will not affect the interest rate on any PowerNotes (SM) offered prior to the effective date of the change.  Prior to the date of this Pricing Supplement, $326.314 mm principal amount of the PowerNotes (SM) were sold at interest rates then in effect.  Subsequent offerings of PowerNotes (SM) will be made under the Prospectus Supplement and Prospectus dated August 8,2002.

Expressed as a percentage of aggregate principal amount.  Actual Price to Public may be less, and will be determined by prevailing market prices at the time of purchase as set forth in the confirmation sheet.
Exhibit 32.1

# Certification Pursuant
to18 U.S.C. §1350, As Adopted Pursuant toSection 906 of the
Sarbanes-Oxley Act of 2002

In
connection with the Quarterly Report of InfoTech USA, Inc. (the Company) on
Form 10-Q for the period ended June 30, 2004, as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, J. Robert Patterson, Vice President, Chief
Financial Officer, Treasurer and Director of the Company,
certify, to the best of my knowledge, pursuant to 18 U.S.C. §1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------

|(2) | The information contained in the Report
          fairly presents, in all material respects, the financial condition and results
          of operations of the Company.
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | /s/ J. Robert Patterson                                                                                                                                                                                                                                                             
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | J. Robert Patterson
                                                     Vice President, Chief Financial Officer, Treasurer andDirector
                                                     InfoTech USA, Inc.
                                                     August 12, 2004
|     |                                                                                                                             |
|-----|-----------------------------------------------------------------------------------------------------------------------------|
| (1) |  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |

|     |                                                                                                                                                             |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) |  The information contained in the Report fairly presents, in all material respects, the financial condition and results of  operations of the Company. |

|        |
|--------|
|        |  |  |
| Date:  | August 2, 2013 | /s/ Kent M. Adams |
|   |   | Kent M. Adams |
|   |   | President, Director and Chief Executive Officer |
|   |   |   |
| Date:  | August 2, 2013 | /s/ James A. Duensing |
|   |   | James A. Duensing |
|   |   | Executive Vice President and Chief FinancialOfficer |
|   |   |
|--------|--------|

**Filed      Pursuant To Rule 433, Registration No. 333-124310**
** **

**$1,000,000,000**

**CATERPILLAR      FINANCIAL SERVICES CORPORATION**

| **For                the Period: 7/10/2006 to                7/17/2006** |
|--------------------------------------------------------------------------|

| **Coupon** | **Interest**                       | **Maturity** | **Callable**     | **Survivor's****Option** | **Price****1** | **Yield****2** | **Moody's** | **S&P** | **CUSIP** |
|------------|------------------------------------|--------------|------------------|--------------------------|----------------|----------------|-------------|-------------|-----------|
| 5.400%     | Semi-Annual(†††) | 7/15/09      | NO               | YES§           | 100.00         | 5.400%         | A2          | A           | 14911Q3Y5 |
| 6.100%     | Semi-Annual(†††) | 7/15/16      | 7/15/08***  | YES§           | 100.00         | 6.099%         | A2          | A           | 14911Q3Z2 |
| 6.200%     | Semi-Annual(†††) | 7/15/18      | 7/15/08***  | YES§           | 100.00         | 6.199%         | A2          | A           | 14911Q4A6 |
| 6.300%     | Semi-Annual(†††) | 7/15/21      | 7/15/09***  | YES§           | 100.00         | 6.300%         | A2          | A           | 14911Q4B4 |

*All      offerings are subject to prior sale.*